LEEANN HRITZ: Open Payments
NPI 1083920060 · NORTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$561 in 32 payments from 8 companies in 2025. Trend: 2023 $2,362 · 2024 $1,367 · 2025 $561
Food & beverage: $462Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $239 |
| Janssen Biotech, Inc. | 2 | $115 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $61 |
| Ipsen Biopharmaceuticals, Inc | 3 | $57 |
| QOL Medical, LLC | 2 | $43 |
| Gilead Sciences, Inc. | 1 | $16 |
| Ardelyx, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
Products named: TREMFYA, RINVOQ, ENTYVIO, SKYRIZI, VIBERZI, Sucraid, IQIRVO, LINZESS.
Industry payments across OH — which companies pay providers there.
